On May one, 2009, there was a recall of fourteen Hydroxycut diet-aid products springing from a number of reports that folks using the products were developing heavy liver issues and other health concerns. Less than seven days later, on May four, the 1st Hydroxycut class action court action was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Class Action Lawsuit alleges company neglectfulness in informing the public about potential dangers of the products. Naturally, it’s too shortly to know how the suit is going to turn out, but if the company had information which it didn’t divulge to customers, it should definitely be held accountable.
A class action lawsuit is filed by a bunch of people, all of whom have similar claims against a certain company. Filing a class action is just as effective, and much less pricey, than filing an individual suit. As a rule, filing a class action court action will not cost anything unless there’s a settlement. At that time, the attorney who handled the suit will take his charges from the compensation that was awarded and then distribute the remaining funds to the plaintiffs in the case. Since this is the case, you’ll be able to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is an example of the explanations that class action lawsuits have become so popular.
The 1st class action lawsuit against Iovate was filed in Canada where the company is located and represents all Canadian citizens who sustained health problems due to Hydroxycut products. The FDA recall took place in the US Where twenty-three cases of liver disorders and other health issues had been reported. Health Canada failed to receive any reports of liver damage due to the diet products, but they did receive 17 reports concerning folks who sustained respiration, neurological, cardiovascular, and stomach problems as a result of Canadians using the products.
The Hydroxycut Liver Damage Suits alleges that the company sold the general public of the health risks that they could exposing consumers to. The complaint states that the company failed to publish the data on the product labels stating that users could run the risk of liver and kidney damage as well as stomach, heart, respiration, and neurological issues. The suit goes on to claim this was a blatant omission on the part of the company which purposely misled consumers concerning the security of the products.
